This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: The Annals of Thoracic Surgery
Author(s): Nicholas J. Goel, Amit Iyengar, John J. Kelly, Chase R. Brown, Fabliha Kurshan, Pavan Atluri, Michael A. Acker, Zehang Chen, Nimesh D. Desai

The readmission rate after mitral valve surgery was 17% among over 75,000 patients in the National Readmissions Database. Predictors included extended initial LOS, chronic lung or renal disease, and low hospital procedural volume for mitral surgery. The mean cost of readmission was over $15,000.

Source: TCTMD
Author(s): Anthony Gershlick, Roxana Mehran, Stuart Pocock, Patrick Serruys, Joseph Sabik III, and Gregg Stone

Following the withdrawal of the support of EACTS for the left main stem chapter of the EACTS/ESC Chapter of the revascularisation guidelines following the BBC Newsnight documentary of this, and the withdrawal of Professor David Taggart as an author of the EXCEL trial published in the NEJM, the EXCEL trial authors have published a very robust defence of their trial that was ten years in the creation and conduct. 

Find the EACTS statement here:

Go straight to the response document from the EXCEL trial here:

Source: JAMA Surgery
Author(s): Chandima Divithotawela, Marcelo Cypel, Tereza Martinu, Lianne G. Singer, Matthew Binnie, Chung-Wai Chow, Cecilia Chaparro, Thomas K. Waddell, Marc de Perrot, Andrew Pierre, Kazuhiro Yasufuku, Jonathan C. Yeung, Laura Donahoe, Shaf Keshavjee, Jussi M. Tikkanen

Donor lungs undergoing EVLP were more injured, but long-term outcomes of transplant were similar between EVLP and non-EVLP lungs, including the incidence of graft dysfunction and survival.

Source: The New England Journal of Medicine
Author(s): Yuki B. Werner, Bengt Hakanson, Jan Martinek, Alessandro Repici, Burkhard H.A. von Rahden, Albert J. Bredenoord, Raf Bisschops, Helmut Messmann, Marius C. Vollberg, Tania Noder, Jan F. Kersten, Oliver Mann, Jakob Izbicki, Alexander Pazdro, Uberto Fumagalli, Riccardo Rosati, Christoph-Thomas Germer, Marlies P. Schijven, Alice Emmermann, Daniel von Renteln, Paul Fockens, Guy Boeckxstaens, Thomas Rösch

A medium-size RCT on the growing research question of efficacy of peroral myotomy for achalasia, with a 17% failure to improve symptoms in the peroral endoscopic myotomy (POEM) arm, is discussed in this article. It recognizes a quite sobering incidence of endoscopically-evidenced reflux esophagitis in both arms, bafflingly improving between 3 and 24 months in the POEM group and increasing in the controls (Dor), while the incidence in the POEM arm was double!

Source: Trials volume 20, Article number: 718 (2019)
Author(s): Tom Treasure, Vern Farewell, Fergus Macbeth, Kathryn Monson, Norman R Williams, Chris Brew-Graves, Belinda Lees, Olivia Grigg, Lesley Fallowfield & PulMiCC Trial Group

The PulMiCC is a randomized clinical trial that tried to build more evidence for performing pulmonary metastasectomy in patients affected by advanced colorectal cancer and previously treated with curative intent. Unfortunately, the trial was stopped earlier becasue of poor recruitment and high drop out rate. The resuts are now published, and the authors question the relevance of performing pulmonary metastasectomy in order to prolong survival.  

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Gui-Qiang Gao, Shang-Dong Xu, Chang-Wei Ren, Sheng Yang, Chao-Liang Liu, Jun Zhen, Yong-Min Liu, Jun-Ming Zhu, Lian-Jun Huang, Li-Zhong Sun

This is a report on outcomes after thoracic endovascular aortic repair (TEVAR) for uncomplicated type B dissection in 751 patients. Ten-year survival was 83% and the 10-year reintervention rate was 10%. The authors concluded that TEVAR may be considered a first choice for patients with uncomplicated type B dissection. 

Source: The Annals of Thoracic Surgery
Author(s): Hari Padmanabhan, Keith Siau, Jason Curtis, Alex Ng, Shyam Menon, Heyman Luckraz, Matthew J. Brookes

This review demonstrates that preoperative anemia is associated with increased mortality, AKI, CVA, and infection after cardiac surgery.  Preoperative anemia appears to be a modifiable risk factor.

Source: Chest
Author(s): Helmneh M. Sineshaw, Liora Sahar, Raymond U. Osarogiagbon, W. Dana Flanders, K. Robin Yabroff, Ahmedin Jemal

Performance of curative surgery for early stage cancer varied considerably among counties in the US, and was related to socioeconomic factors, availability of surgeons, and non-metropolitan status. 

Source: Journal of the American College of Surgeons
Author(s): Charles A. Mouch, Brooke C. Kenney, Shawna Lorch, John R. Montgomery, Monica Gonzalez-Walker, Kathy Bishop, William C. Palazzolo, June A. Sullivan, Stewart C. Wang, Michael J. Englesbe

Medicare claims data were reviewed for patients in Michigan who underwent inpatient surgery. Some patients were enrolled in prehabilitation programs consisting of home-based walking exercise, nutrition, smoking cessation, and stress reduction. Patients undergoing prehabilitation were compared to similar patients undergoing surgery at the same hospitals but who did not enroll in the program. Patients undergoing prehabilitation had shorter LOS, lower costs of care, and were more likely to be discharged to home.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Osnat Itzhaki Ben Zadok, Ben Ben-Avraham, Aviv Shaul, Yoav Hammer, Victor Rubachevski, Dan Aravot, Ran Kornowski, Tuvia Ben-Gal

The authors analyzed the outcomes of the continuous-flow left ventricular assist devices. The study includes 105 patients supported with HM2 (N=54), HM3 (N=25), and HW (N-26). Eighteen-month data suggested that HM3 had a better prognostic and adverse-event profile over other devices.